1034

GDT Ontario Health Testing Eligibility Cardiomyopathy and Arrhythmia GTD Indications Diagnosis Carrier / Cascade Testing Prenatal GTD Samples Accepted Blood DNA Cultured Cells Amniocyte CVS GTD Test Methodology CNV Sequencing GTD Methodology Notes Oligonucleotide based target capture, Sanger if low coverage, MLPA (BAG3, MYH7, MYBPC3, PKP2, and TNNT2) Generic Test name (cms title) Cardiomyopathy GTD Test type Gene Panel GTD Location Children's Hospital of Eastern Ontario GTD Gene/Platform/Region List BAG3, DES, DSC2, DSG2, DSP, FLNC, GLA, JUP, LAMP2, LMNA, MYH7, MYL2, MYL3, NEXN, PKP2, PLN, PRKAG2, RBM20, SCN5A, TMEM (43 c.1073C>T), TNNI3, TNNT2, TPM1, TTN, TTR, ACTC1, ACTN2, MYBPC3, TNNC1, VCL
GTD Category Cardiogenetics GTD Disease/Condition Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC), Uhl anomaly and right ventricular dysplasia, arrhythmogenic right ventricular dysplasia (ARVD), Hypertrophic Cardiomyopathy (HCM), Heritable hypertrophic cardiomyopathy, Familial HCM, Cardiomyopathy familial hypertrophic, Dilated cardiomyopathy (DCM)